Clinical trial

Pilot Study With GFT505 (80mg) in Patients Presenting With Impaired Glucose Tolerance and Abdominal Obesity.

NCT01275469

Study summary

ClinicalTrials.gov

Pilot Study With GFT505 (80mg) in Patients Presenting With Impaired Glucose Tolerance and Abdominal Obesity.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention GFT505 80mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-06-01

PhasePHASE2

Conditions

Impaired Glucose Toleranceunresolved

Abdominal Obesityunresolved

Interventions

GFT505 80mgDRUG

PlaceboDRUG

Sponsors & collaborators

Genfitlead sponsor

Mapped research locations

AngersFrance7 ParisFrance1 NantesFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01275469 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.